These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 15951293

  • 21. [Survival of patients with aggressive non-hodgkin's lymphoma: no difference between first line treatment in a prospective randomised phase III clinical trial and first line treatment according to routine clinical practice].
    van Agthoven M, Wittebol S, Budel LM, Uyl-de Groot CA, Kramer MH.
    Ned Tijdschr Geneeskd; 2004 Jan 10; 148(2):88-93. PubMed ID: 14753131
    [Abstract] [Full Text] [Related]

  • 22. [Clinical comparison of CHO regimen versus CHOP regimen for treatment of patients with intermediate-grade non-Hodgkin's lymphoma].
    Yuan ZY, Xu RH, He YJ, Guan ZZ.
    Ai Zheng; 2003 Apr 10; 22(4):393-6. PubMed ID: 12703996
    [Abstract] [Full Text] [Related]

  • 23. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
    Rigacci L, Carrai V, Nassi L, Alterini R, Longo G, Bernardi F, Bosi A.
    Cancer; 2005 Mar 01; 103(5):970-7. PubMed ID: 15666323
    [Abstract] [Full Text] [Related]

  • 24. A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized study.
    Takagi T, Sampi K, Sawada U, Sakai C, Oguro M.
    Int J Hematol; 1993 Jan 01; 57(1):67-71. PubMed ID: 8477064
    [Abstract] [Full Text] [Related]

  • 25. [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].
    Huang HQ, Peng YL, Lin XB, Sun XF, Lin TY, Xia ZJ, Li YH, Cai QQ, He YJ, Jiang WQ, Guan ZZ.
    Ai Zheng; 2004 Nov 01; 23(11 Suppl):1443-7. PubMed ID: 15566653
    [Abstract] [Full Text] [Related]

  • 26. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY, Hu DS, Zeng FY, Song QB, Hu S, Wei L, Zhou LQ.
    Ai Zheng; 2007 Dec 01; 26(12):1360-4. PubMed ID: 18076802
    [Abstract] [Full Text] [Related]

  • 27. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
    van Imhoff GW, van der Holt B, Mackenzie MA, Van't Veer MB, Wijermans PW, Ossenkoppele GJ, Schouten HC, Sonneveld P, Steijaert MM, Kluin PM, Kluin-Nelemans HC, Verdonck LF, Dutch-Belgian Hemato-Oncology Cooperative Group.
    J Clin Oncol; 2005 Jun 01; 23(16):3793-801. PubMed ID: 15809447
    [Abstract] [Full Text] [Related]

  • 28. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
    Reyes F, Lepage E, Ganem G, Molina TJ, Brice P, Coiffier B, Morel P, Ferme C, Bosly A, Lederlin P, Laurent G, Tilly H, Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    N Engl J Med; 2005 Mar 24; 352(12):1197-205. PubMed ID: 15788496
    [Abstract] [Full Text] [Related]

  • 29. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):208-18. PubMed ID: 15093918
    [Abstract] [Full Text] [Related]

  • 30. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
    Hoederath A, Sack H, Stuschke M, Lampka E.
    Strahlenther Onkol; 1996 Jul 01; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
    [Abstract] [Full Text] [Related]

  • 31. Non-Hodgkin's lymphoma in the elderly: the impact of advanced age on therapeutic options and clinical results.
    Orlandi E, Lazzarino M, Brusamolino E, Castelli G, Pagnucco G, Morra E, Bernasconi C.
    Haematologica; 1991 Jul 01; 76(3):204-8. PubMed ID: 1743590
    [Abstract] [Full Text] [Related]

  • 32. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
    Viviani S, Bonfante V, Santoro A, Zanini M, Devizzi L, Di Russo AD, Soncini F, Villani F, Ragni G, Valagussa P, Bonadonna G.
    Cancer J Sci Am; 1999 Jul 01; 5(5):275-82. PubMed ID: 10526668
    [Abstract] [Full Text] [Related]

  • 33. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T, Tsuchiya K, Nishioka S, Kitahara T, Ohmori K, Homma A, Aoyma H, Shindoh M, Shirato H.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):847-52. PubMed ID: 15465202
    [Abstract] [Full Text] [Related]

  • 34. [Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases].
    Li QC, Yuan XL, Wang YF, Zou DH, Zhao YZ, Qiu LG.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):254-7. PubMed ID: 18361837
    [Abstract] [Full Text] [Related]

  • 35. [Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma].
    Yong W, Zheng W, Zhang Y.
    Zhonghua Yi Xue Za Zhi; 2001 Jul 10; 81(13):773-5. PubMed ID: 11798962
    [Abstract] [Full Text] [Related]

  • 36. Radiotherapy for localized relapse in patients with non-Hodgkin's lymphoma: a preliminary report.
    Nakamura K, Kunitake N, Kimura M, Shioyama Y, Terashima H, Masuda K.
    Radiat Med; 2000 Jul 10; 18(4):245-8. PubMed ID: 11247000
    [Abstract] [Full Text] [Related]

  • 37. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P, Passon J, Ebeling P, Welt A, Müller S, Metz K, Moritz T, Seeber S, Nowrousian MR.
    Eur J Haematol; 2007 Feb 10; 78(2):93-101. PubMed ID: 17313557
    [Abstract] [Full Text] [Related]

  • 38. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
    Czuczman MS, Weaver R, Alkuzweny B, Berlfein J, Grillo-López AJ.
    J Clin Oncol; 2004 Dec 01; 22(23):4711-6. PubMed ID: 15483015
    [Abstract] [Full Text] [Related]

  • 39. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169
    [Abstract] [Full Text] [Related]

  • 40. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
    Moser EC, Noordijk EM, van Leeuwen FE, Baars JW, Thomas J, Carde P, Meerwaldt JH, van Glabbeke M, Kluin-Nelemans HC.
    Haematologica; 2006 Nov 01; 91(11):1481-8. PubMed ID: 17043014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.